StockIQ.techRhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis
Free AI-powered analysis and research for Rhythm Pharmaceuticals, Inc. stock
Sector: Healthcare
Full RYTM report
Rhythm Pharmaceuticals, Inc. (RYTM) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze RYTM Now →📰 Latest Update
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Beats Revenue Estimates
Tue, November 3, 2026 at 12:15 PM UTC 2 min read
Rhythm Pharmaceuticals, Inc. (RYTM) reported a Q3 loss of $0.61 per share, beating the Zacks Consensus Estimate of a loss of $0.68, and showing improvement from a loss of $0.82 per share a year ago. The company also surpassed revenue expectations with $92.13 million, exceeding estimates by 9.07% and up from $51.3 million year-over-year. Despite these positive results, RYTM shares have declined about 12.7% since the start of the year, underperforming the S&P 500's 10.2% gain.